Invacare Corporation
IVCNYSEHealthcare
$0.66
+$0.00(+0.00%)
Market Cap$24910286
P/E Ratio—
52W High$2.53
52W Low$0.0241
Invacare Corporation (IVC) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
IVC · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2023Report Date: May 8, 2023EPS Actual
-$1.08
Est. -$0.55 · -96.8%
Revenue
$0.17B
Est. $0.18B · -5.5%
Fiscal Period
Q2 FY2023
FY ends December
Report Date
May 8, 2023
After Market Close
▼ Miss EPS▼ Miss Revenue
IVC reports quarterly as a NYSE-listed Medical - Instruments & Supplies company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ▼ Q2 FY2023 | May 8, 2023 | -$0.55 | -$1.08 | -96.8% | $0.17B | $0.18B | -5.5% |
| — Q1 FY2023 | Mar 14, 2023 | — | -$0.56 | — | $0.18B | $0.17B | +3.8% |
| ▼ Q4 FY2022 | Nov 7, 2022 | -$0.39 | -$0.92 | -135.9% | $0.17B | — | — |
| ▼ Q3 FY2022 | Aug 8, 2022 | -$0.42 | -$0.62 | -47.6% | $0.19B | — | — |
| ▼ Q2 FY2022 | May 9, 2022 | -$0.43 | -$0.69 | -60.5% | $0.20B | $0.20B | +2.4% |
| ▲ Q1 FY2022 | Mar 8, 2022 | $0.02 | $0.08 | +300.0% | $0.23B | $0.20B | +14.6% |
| ▲ Q4 FY2021 | Oct 27, 2021 | -$0.19 | -$0.12 | +36.8% | $0.22B | $0.24B | -5.0% |
| ▼ Q3 FY2021 | Aug 4, 2021 | -$0.23 | -$0.28 | -21.7% | $0.23B | $0.21B | +5.3% |
Q2 FY2023
May 8, 2023Miss
EPS Actual
-$1.08
EPS Est.
-$0.55
EPS Surpr.
-96.8%
Revenue
$0.17B
Q1 FY2023
Mar 14, 2023
EPS Actual
-$0.56
EPS Est.
—
EPS Surpr.
—
Revenue
$0.18B
Q4 FY2022
Nov 7, 2022Miss
EPS Actual
-$0.92
EPS Est.
-$0.39
EPS Surpr.
-135.9%
Revenue
$0.17B
Q3 FY2022
Aug 8, 2022Miss
EPS Actual
-$0.62
EPS Est.
-$0.42
EPS Surpr.
-47.6%
Revenue
$0.19B
Q2 FY2022
May 9, 2022Miss
EPS Actual
-$0.69
EPS Est.
-$0.43
EPS Surpr.
-60.5%
Revenue
$0.20B
Q1 FY2022
Mar 8, 2022Beat
EPS Actual
$0.08
EPS Est.
$0.02
EPS Surpr.
+300.0%
Revenue
$0.23B
Q4 FY2021
Oct 27, 2021Beat
EPS Actual
-$0.12
EPS Est.
-$0.19
EPS Surpr.
+36.8%
Revenue
$0.22B
Q3 FY2021
Aug 4, 2021Miss
EPS Actual
-$0.28
EPS Est.
-$0.23
EPS Surpr.
-21.7%
Revenue
$0.23B
No analyst estimates available for IVC.
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2023 | May 8, 2023 | -96.8% | $0.66 | — | — |
| — Q1 FY2023 | Mar 14, 2023 | — | $0.66 | — | — |
| ▼ Q4 FY2022 | Nov 7, 2022 | -135.9% | $0.73 | $0.66 | -9.51% |
| ▼ Q3 FY2022 | Aug 8, 2022 | -47.6% | $1.14 | $1.10 | -3.51% |
| ▼ Q2 FY2022 | May 9, 2022 | -60.5% | $1.49 | $1.38 | -7.38% |
| ▲ Q1 FY2022 | Mar 8, 2022 | +300.0% | $2.23 | $2.34 | +4.93% |
| ▲ Q4 FY2021 | Oct 27, 2021 | +36.8% | $4.56 | $4.40 | -3.51% |
| ▼ Q3 FY2021 | Aug 4, 2021 | -21.7% | $6.98 | $6.97 | -0.14% |
Q2 FY2023—
Report Date
May 8, 2023
EPS Beat/Miss
-96.8%
Price Before
$0.66
Price After
—
Q1 FY2023—
Report Date
Mar 14, 2023
EPS Beat/Miss
—
Price Before
$0.66
Price After
—
Q4 FY2022-9.51%
Report Date
Nov 7, 2022
EPS Beat/Miss
-135.9%
Price Before
$0.73
Price After
$0.66
Q3 FY2022-3.51%
Report Date
Aug 8, 2022
EPS Beat/Miss
-47.6%
Price Before
$1.14
Price After
$1.10
Q2 FY2022-7.38%
Report Date
May 9, 2022
EPS Beat/Miss
-60.5%
Price Before
$1.49
Price After
$1.38
Q1 FY2022+4.93%
Report Date
Mar 8, 2022
EPS Beat/Miss
+300.0%
Price Before
$2.23
Price After
$2.34
Q4 FY2021-3.51%
Report Date
Oct 27, 2021
EPS Beat/Miss
+36.8%
Price Before
$4.56
Price After
$4.40
Q3 FY2021-0.14%
Report Date
Aug 4, 2021
EPS Beat/Miss
-21.7%
Price Before
$6.98
Price After
$6.97
Avg Beat Reaction+0.71%
Avg Miss Reaction-5.13%
Beat Rate2 / 8 quarters
Largest Move-9.51% (Q4 FY2022)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: IVC ends December
Invacare Corporation (IVC) most recently reported earnings on May 8, 2023 for Q2 FY2023, posting EPS of $-1.08 — missing the analyst consensus of $-0.55 by -96.8%. The next IVC earnings date is expected around September 1, 2026.
Each quarter, investors track IVC earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. IVC revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
IVC's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
IVC earnings · 5 questionsInvacare Corporation's next earnings report is expected around September 1, 2026. IVC typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; IVC historically reports after market close (AMC).
IVC earnings datewhen is IVC earningsIVC next earnings datewhen does IVC report earningsIVC earnings calendar
▸ Source: FMP · Invacare Corporation SEC filings · US GAAP · Invacare Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026